IEIreland 16°C Partly Cloudy · Dublin AQI: Good
--:--:-- IST Writer Login
LATEST
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
MARKETS
Priya Life Sciences
Write for Us LinkedIn Tool Free Tools
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected
BREAKING REGULATORY AFFAIRS
REGULATORY AFFAIRS · IN-DEPTH

The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected

Sreepriya Prasannan · 1 days ago · 7 min read

Live Feed

auto · hover to pause
REGULATORY AFFAIRS

The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected

1 days ago
REGULATORY AFFAIRS

Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots

1 days ago
MEDTECH

Cork MedTech Innovator NeuroBell Secures $5.5M to Accelerate Launch of AI Neonatal Seizure Monitor Luna

2 days ago
INDUSTRY

Tapestry VC Closes $80M Fund III Backed by British Business Bank to Target Repeat Founders

2 days ago
MEDTECH

AI Real Estate Pioneer Build Raises $8.5M Seed Round to Automate Infrastructure Workflows

2 days ago
INDUSTRY

GovTech Startup Xylo Raises £2.8M Led by CapitalT to Solve Local Council Planning Bottlenecks

2 days ago
REGULATORY AFFAIRS

Data Integrity and Quality Oversight: Analyzing the FDA Warning Letter for Sanofi's Waterford Site

3 days ago
REGULATORY AFFAIRS

A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals

4 days ago
REGULATORY AFFAIRS

The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026

6 days ago
INDUSTRY

Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs

6 days ago
REGULATORY AFFAIRS

FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings

6 days ago
PHARMACEUTICAL

Cold Chain Management and Good Distribution Practice (GDP) for Biologics and Vaccines

30 Jun 2026
REGULATORY AFFAIRS

The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected

1 days ago
REGULATORY AFFAIRS

Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots

1 days ago
MEDTECH

Cork MedTech Innovator NeuroBell Secures $5.5M to Accelerate Launch of AI Neonatal Seizure Monitor Luna

2 days ago
INDUSTRY

Tapestry VC Closes $80M Fund III Backed by British Business Bank to Target Repeat Founders

2 days ago
MEDTECH

AI Real Estate Pioneer Build Raises $8.5M Seed Round to Automate Infrastructure Workflows

2 days ago
INDUSTRY

GovTech Startup Xylo Raises £2.8M Led by CapitalT to Solve Local Council Planning Bottlenecks

2 days ago
REGULATORY AFFAIRS

Data Integrity and Quality Oversight: Analyzing the FDA Warning Letter for Sanofi's Waterford Site

3 days ago
REGULATORY AFFAIRS

A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals

4 days ago
REGULATORY AFFAIRS

The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026

6 days ago
INDUSTRY

Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs

6 days ago
REGULATORY AFFAIRS

FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings

6 days ago
PHARMACEUTICAL

Cold Chain Management and Good Distribution Practice (GDP) for Biologics and Vaccines

30 Jun 2026
AUDIO BRIEFING · GENERATING…
Generating audio briefing — check back shortly
Ireland · en-IE Voice
135+
Articles Published
7
Topic Categories
16,211+
Monthly Views
1
Expert Authors
14+
Free Career Tools
All News Biotechnology Clinical Trials Industry MedTech Pharmaceutical Regulatory Affairs
LATEST INTELLIGENCE

Today's Most Important Stories

Critical updates across pharma, biotech, regulatory affairs, and life-science careers in Ireland and the EU.

View All News →
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected
REGULATORY AFFAIRS · FEATURED

The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected

Jefferies has revised its debut-quarter US sales estimate for Eli Lilly's oral GLP-1 drug Foundayo (orforglipron) down to $71 million — well below the Wall Street consensus of $130 million and sharply below its own prior estimate of $85 million. With weekly prescriptions hovering around 20,000 and Novo Nordisk's oral Wegovy outpacing it on trajectory, the first oral non-peptide GLP-1 for obesity is generating a very different story than the hype suggested.

Sreepriya Prasannan · 1 days ago · 7 min read
01
REGULATORY AFFAIRS

Irish Pharma Salary Guide 2026: What QC Analysts, Engineers and Bioprocess Operators Are Earning

Sreepriya Prasannan · 02 Jun 2026
02
LINKEDIN

10 LinkedIn Profile Fixes That Will Get You Noticed by Irish Pharma Recruiters in 2026

Sreepriya Prasannan · 02 Jun 2026
03
LINKEDIN

How to Create a LinkedIn Profile Using AI: The 2026 Guide for Life Science Professionals

Sreepriya Prasannan · 15 Jun 2026
04
LINKEDIN

10 LinkedIn Headline Examples for Life Science Professionals in Ireland

Sreepriya Prasannan · 22 Mar 2026
05
REGULATORY AFFAIRS

EU GMP Annex 1 in 2026: What Every Sterile Manufacturing Professional in Ireland Must Know

Sreepriya Prasannan · 02 Jun 2026
CURATED INTELLIGENCE

What Everyone's Reading

All Articles →
Trending This Week Editor's Picks Exclusives In-Depth Intelligence

Live Market Dashboard

Real-time pharma equities intelligence

Loading... -- --
1D 1W 1M 1Y

Live Data & Intelligence

Self-updating datasets built from official registries — refreshed daily

Clinical Trials Tracker
49 trials recruiting in Ireland right now
97 active studies at Irish hospitals and research sites — searchable by condition, sponsor, phase and city. From ClinicalTrials.gov.
Explore the tracker →
Irish Medicines Database
10,165 authorised medicines
Every HPRA-licensed product on the Irish market — search by brand, active substance or company, with licence details for each.
Search the database →
Free Tool · CV Studio
13 ATS-tested CV templates
Build a recruiter-ready life science CV free: live preview, AI tailoring, ATS score check, PDF and Word export. No account, data stays on your device.
Build your CV →

Explore by Topic

Navigate Ireland's pharma landscape

Biotechnology
9 articles
Clinical Trials
5 articles
Industry
39 articles
LinkedIn
10 articles
Long-form intelligence for industry leaders
IN-DEPTH

Tapestry VC Closes $80M Fund III Backed by British Business Bank to Target Repeat Founders

Co-founded by Patrick Murphy and David Kelly, Tapestry VC has announced the closing of its $80 million Fund III, tripling its capital base with support from OpenAI CFO Sarah Friar and the British Business Bank.

Sreepriya Prasannan · 2 days ago · 2 min read
MEDTECH

AI Real Estate Pioneer Build Raises $8.5M Seed Round to Automate Infrastructure Workflows

Build, a startup co-founded by James Stirrat-Ellis and Ben McClusky, has secured $8.5 million in seed funding led by Index Ventures to expand Dougie, its AI platform for real estate infrastructure workflows.

Sreepriya Prasannan · 2 days ago
INDUSTRY

GovTech Startup Xylo Raises £2.8M Led by CapitalT to Solve Local Council Planning Bottlenecks

Co-founded by Habs Isabelle Kim and Dermot O'Riordan, government technology startup Xylo has raised £2.8 million in pre-seed funding to deploy AI agents that speed up local planning departments.

Sreepriya Prasannan · 2 days ago

AI-Powered Tools

Built for Irish pharma professionals

NOW HIRING

Launch Your Life Science
Career in Ireland

Discover roles at MSD, Pfizer, J&J, Regeneron and 280+ Irish pharma employers. Get matched to your next opportunity.

Browse Open Roles Post a Job
EMPLOYERS
MSD Ireland Pfizer Johnson & Johnson Regeneron AstraZeneca Eli Lilly Takeda Novartis Bristol Myers Squibb AbbVie Roche MSD Ireland Pfizer Johnson & Johnson Regeneron AstraZeneca Eli Lilly Takeda Novartis Bristol Myers Squibb AbbVie Roche

The Irish Pharma Intelligence Brief

Weekly. Free. Used by 14,000+ pharma professionals across Ireland. No fluff — just signal.

Breaking regulatory news from EMA & HPRA
Investment & deal-flow tracker
Career moves & salary intelligence
Exclusive interviews with industry leaders

No spam. Unsubscribe any time. GDPR compliant.